From: The aging lung: tissue telomere shortening in health and disease
 | NORMAL | CF | COPD | cHP | BOS | RAS |
---|---|---|---|---|---|---|
Subjects, n | 13 | 12 | 11 | 9 | 11 | 14 |
Lung age, years | 48 (20) | 23 (7)* | 60 (3) | 58 (10) | 27 (24) | 46 (23) |
Lung age, range | 16-72 | 19-33 | 48-61 | 36-61 | 16-48 | 9-61 |
Male, n (%) | 10 (77) | 5 (42) | 5 (45) | 4 (44) | 5 (45) | 8 (57) |
Male donor, n (%) | NA | NA | NA | NA | 5 (45) | 8 (57) |
Patient height, cm | 175 (15) | 162 (18) | 163 (22) | 166 (19) | 168 (12) | 168 (17) |
Patient weight, kg | 80 (25) | 46 (14)*** | 60 (17) | 74 (9) | 51 (21)** | 60 (21)* |
BMI, kg/m2 | 25 (4) | 18 (2)*** | 21 (8) | 27 (4) | 18 (5)** | 19 (6)** |
FEV1, L | NA | 0.8 (0.4) | 0.8 (0.5) | 1.1 (0.8) | 0.6 (0.3) | 0.9 (0.5) |
FEV1, % predicted | NA | 23 (10) | 31 (11) | 49 (21) | 20 (3) | 26 (12) |
FVC, L | NA | 1.6 (0.8) | 2.0 (0.4) | 1.3 (0.9) | 1.5 (1) | 1.4 (0.6) |
FVC, % predicted | NA | 45 (15) | 66 (33) | 38 (20) | 46 (20) | 33 (13) |
FEV1/FVC | NA | 0.5 (0.1) | 0.4 (0.1) | 0.9 (0.2) | 0.4 (0.1) | 0.7 (0.3) |
DLco, % predicted | NA | 38 (33)a | 33 (14) | 30 (7) | 40 (18)b | 35 (8)c |